Vazkepa (icosapent ethyl) clinical trials

NLRP3 and SASP in Vazkepa therapy in patients with heart disease with or without type 2 diabetes

This study looks at how a medicine called Vazkepa works in people with heart disease, with or without diabetes. We want to see if it reduces inflammation, which might explain why it lowers the risk of heart attacks and strokes.